<?xml version='1.0' encoding='utf-8'?>
<document id="30423339"><sentence text="Predicting the Changes in Oral Absorption of Weak Base Drugs Under Elevated Gastric pH Using an In Vitro-In Silico-In Vivo Approach: Case Examples-Dipyridamole, Prasugrel, and Nelfinavir."><entity charOffset="161-170" id="DDI-PubMed.30423339.s1.e0" text="Prasugrel" /><entity charOffset="176-186" id="DDI-PubMed.30423339.s1.e1" text="Nelfinavir" /><pair ddi="false" e1="DDI-PubMed.30423339.s1.e0" e2="DDI-PubMed.30423339.s1.e0" /><pair ddi="false" e1="DDI-PubMed.30423339.s1.e0" e2="DDI-PubMed.30423339.s1.e1" /></sentence><sentence text="The aim of the current research was to develop an in silico oral absorption model coupled with an in vitro dissolution/precipitation testing to predict gastric pH-dependent drug-drug interactions for weakly basic drugs" /><sentence text=" The effects of elevated gastric pH on the plasma profiles of dipyridamole, prasugrel, and nelfinavir were simulated and compared with pharmacokinetic data reported in humans with or without use of proton pump inhibitors or histamine H2 receptor antagonists"><entity charOffset="62-74" id="DDI-PubMed.30423339.s3.e0" text="dipyridamole" /><entity charOffset="76-85" id="DDI-PubMed.30423339.s3.e1" text="prasugrel" /><entity charOffset="91-101" id="DDI-PubMed.30423339.s3.e2" text="nelfinavir" /><entity charOffset="224-233" id="DDI-PubMed.30423339.s3.e3" text="histamine" /><pair ddi="false" e1="DDI-PubMed.30423339.s3.e0" e2="DDI-PubMed.30423339.s3.e0" /><pair ddi="false" e1="DDI-PubMed.30423339.s3.e0" e2="DDI-PubMed.30423339.s3.e1" /><pair ddi="false" e1="DDI-PubMed.30423339.s3.e0" e2="DDI-PubMed.30423339.s3.e2" /><pair ddi="false" e1="DDI-PubMed.30423339.s3.e0" e2="DDI-PubMed.30423339.s3.e3" /><pair ddi="false" e1="DDI-PubMed.30423339.s3.e1" e2="DDI-PubMed.30423339.s3.e1" /><pair ddi="false" e1="DDI-PubMed.30423339.s3.e1" e2="DDI-PubMed.30423339.s3.e2" /><pair ddi="false" e1="DDI-PubMed.30423339.s3.e1" e2="DDI-PubMed.30423339.s3.e3" /><pair ddi="false" e1="DDI-PubMed.30423339.s3.e2" e2="DDI-PubMed.30423339.s3.e2" /><pair ddi="false" e1="DDI-PubMed.30423339.s3.e2" e2="DDI-PubMed.30423339.s3.e3" /></sentence><sentence text=" The in vitro dissolution and precipitation data for the weakly basic drugs in biorelevant media were obtained using paddle apparatus" /><sentence text=" An in silico prediction model based on the STELLA software was designed and simulations were conducted to predict the oral pharmacokinetic profiles of the 3 drugs under both usual (low) and elevated gastric pH conditions" /><sentence text=" The changes in oral absorption of dipyridamole and prasugrel in subjects with elevated gastric pH compared with those with low stomach pH were predicted well using the in vitro-in silico-in vivo approach"><entity charOffset="35-47" id="DDI-PubMed.30423339.s6.e0" text="dipyridamole" /><entity charOffset="52-61" id="DDI-PubMed.30423339.s6.e1" text="prasugrel" /><pair ddi="false" e1="DDI-PubMed.30423339.s6.e0" e2="DDI-PubMed.30423339.s6.e0" /><pair ddi="false" e1="DDI-PubMed.30423339.s6.e0" e2="DDI-PubMed.30423339.s6.e1" /></sentence><sentence text=" The proposed approach could become a powerful tool in the formulation development of poorly soluble weak base drugs" /><sentence text="" /></document>